Epidemiology, Pathogenesis, and Pathophysiology of Urolithiasis

Slides:

Advertisements

Similar presentations

Medical Management for BPH: The Role of Combination Therapy

Advertisements

Pascal Rischmann European Urology Supplements

Volume 197, Issue 4, Pages e236-e237 (April 2017)

Prostate Cancer 2008: Challenges in Diagnosis and Management

2004 World Health Organization Classification of the Noninvasive Urothelial Neoplasms: Inherent Problems and Clinical Reflections Rodolfo Montironi,

Management of Acute and Chronic Retention in Men

Management of the Urologic Sepsis Syndrome

Shock Wave Lithotripsy for Renal and Ureteric Stones

Who Benefits from Neoadjuvant or Adjuvant Hormone Therapy?

Shock Wave Lithotripsy for Renal and Ureteric Stones

Martin C. Michel European Urology Supplements

Treatment of Advanced and Metastatic Renal Cancer: A Revolution?

Bladder Cancer: A Major Public Health Issue

Back to the Future: Introduction and Conclusions

Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) Survey John B. McKinlay, Carol L. Link European.

Long-Term Management of Overactive Bladder with Antimuscarinic Agents

P.M.J. Moonen, L.A.L.M. Kiemeney, J.A. Witjes European Urology

A Novel Treatment of Premature Ejaculation

Counselling the Prostate Cancer Patient

Laurent Boccon-Gibod European Urology Supplements

James N. Armitage, Stuart O. Irving, Neil A. Burgess European Urology

Current Status of Combined Radiation Therapy and Androgen Suppression in Locally Advanced Prostate Cancer: What Is the Way Forward? Michel Bolla European.

An Update of Current Practice in Hypospadias Surgery

Use of the National Health and Nutrition Examination Survey to Calculate the Impact of Obesity and Diabetes on Cost and Prevalence of Urolithiasis in.

Richard C. Harkaway European Urology Supplements

Karl-Dietrich Sievert, Bastian Amend, Arnulf Stenzl European Urology

Tim Schneider European Urology Supplements

Optimal Control of Testosterone: A Clinical Case-Based Approach of Modern Androgen- Deprivation Therapy Bertrand Tombal, Richard Berges European Urology.

Ian Milsom European Urology Supplements

The Importance of Testosterone Control in Prostate Cancer

Laparoscopic Cryoablation of Small Renal Masses: Technique and Results after 6-Year Experience Andrea Cestari, Giorgio Guazzoni, Nicolò Maria Buffi,

Insights into the Relationships between Prostatic Disorders and Their Potential Impact on Future Urologic Practice Claus Roehrborn European Urology.

Neal Shore European Urology Supplements

Ileal Neobladder and Its Variants

Sergio Bracarda European Urology Supplements

Pharmacotherapy in Stress and Mixed Incontinence

Christian Stief European Urology Supplements

European Urology is “Your” Journal

New Trends in Managing the Prostate Cancer Patient

Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders

Emmanuel Chartier-Kastler, Kate Davidson European Urology Supplements

A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study John Fitzpatrick European.

Who Forms Stones and Why?

Prostate Cancer 2008: Challenges in Diagnosis and Management

Martin Michel, Jean de la Rosette European Urology Supplements

Retrocaval Ureter—Magnetic Resonance Appearances

The European Online Sexual Survey (EOSS): Pan-European Perspectives on the Impact of Premature Ejaculation and Treatment-Seeking Behavior John Dean

Improving Flexibility and Quality of Life for Your Patients: A Must?

The Burden of Stress Urinary Incontinence

Profile of Silodosin European Urology Supplements

Robotic Cystectomy Versus Open Cystectomy: Are We There Yet?

Stone Disease European Urology Supplements

New Concepts in Epidemiology of Lower Urinary Tract Symptoms in Men

Improving Stone Clearance After Extracorporeal Shock Wave Lithotripsy in Urolithiasis Patients by a Special Terpene Combination (Rowatinex®): Results.

Prognostic Factors in Non–Muscle-Invasive Bladder Tumors

Treatment Options in Prostate Cancer Once Primary Therapy Fails

Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer Sten Holmäng European Urology.

Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma Jan Roigas European Urology Supplements Volume.

Reviewer Acknowledgment

Joaquim Bellmunt European Urology Supplements

Classification of Mixed Incontinence

The Impact of Premature Ejaculation on Partners and Relationships

Oncoforum Urology: Prostate Cancer 2008 at a Glance

Emmanuel Chartier-Kastler, Andrea Tubaro European Urology Supplements

Diagnosis and Management of Cryptorchidism

Epidemiology and Demographics of Prostatitis

Jan Roigas European Urology Supplements

Pathology and Molecular Pathogenesis of Renal Cell Carcinoma

Volume 51, Issue 5, Pages (May 2007)

Michael Marberger European Urology Supplements

Presentation transcript:

Epidemiology, Pathogenesis, and Pathophysiology of Urolithiasis Thomas Knoll European Urology Supplements Volume 9, Issue 12, Pages 802-806 (December 2010) DOI: 10.1016/j.eursup.2010.11.006 Copyright © 2010 European Association of Urology Terms and Conditions

Fig. 1 Frequency of hydroxyapatite, brushite, and calcium oxalate components in urinary stones, 1980–2004 (n=111 196). European Urology Supplements 2010 9, 802-806DOI: (10.1016/j.eursup.2010.11.006) Copyright © 2010 European Association of Urology Terms and Conditions

Fig. 2 Microcalcifications on renal papilla are thought to be precursors of calcium oxalate stones (Randall plaques). European Urology Supplements 2010 9, 802-806DOI: (10.1016/j.eursup.2010.11.006) Copyright © 2010 European Association of Urology Terms and Conditions